Prevalence of plexiform neurofibroma in children and adolescents with type I neurofibromatosis.
To assess prevalence of plexiform neurofibroma in children and adolescents with type I neurofibromatosis and its malignant potential.



A retrospective study was conducted through analysis of the database at Centro Nacional de Neurofibromatose [Brazilian Neurofibromatosis Center], collected from the following reference services between 1996 and 2004: Instituto de Dermatologia Prof. Rubem David Azulay da Santa Casa de Misericórdia do Rio de Janeiro, Instituto de Pediatria e Puericultura Martagão Gesteira da Universidade Federal do Rio de Janeiro and Department of Immunology and Microbiology at Faculdade de Medicina de Teresópolis.



Over that period, 104 patients aged between 1-17 years were admitted with clinical diagnosis of type I neurofibromatosis. Of these, 53 were male and 51 were female, and 28 patients (15 male and 13 female) had plexiform neurofibroma (26.9%). Division by age group resulted in 21.42% (six) between 1-5 years; 35.71% (10) between 6-12 years and 42.85% (12) between 13-17 years. Of the 104 patients, two developed a malignant peripheral nerve sheath tumor (1.92%).



Plexiform neurofibromas are relatively common manifestations in patients with type I neurofibromatosis and may be a cause of significant increase in morbidity and mortality among patients. In this study, we conclude that frequency of plexiform neurofibroma and its malignant potential in the population studied is in agreement with data from the international literature.
Darrigo
Luiz G
LG
Universidade de São Paulo (USP), São Paulo, SP, Brazil. guimedicina@gmail.com
Geller
Mauro
M
Bonalumi Filho
Aguinaldo
A
Azulay
David R
DR
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D018318:Neurofibroma, Plexiform / Q000175:diagnosis / Q000453:epidemiology*; D009456:Neurofibromatosis 1 / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies